Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Menu

    Mesdopetam

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Publishes Ph 2b Mesdopetam Data In Movement Disorders
    IRLAB Publishes Ph 2b Mesdopetam Data In Movement Disorders

    27 Feb 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-publishes-phase-iib-data-on-mesdopetam-in-movement-disorders-cli-992587

    ACCESSWIRE
    27 Feb 2025
    Share Share
    Irlab Gets EMA Waiver For Pediatric Mesdopetam Parkinson’s Studies
    Irlab Gets EMA Waiver For Pediatric Mesdopetam Parkinson’s Studies

    23 Jan 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-has-received-a-waiver-from-the-ema-regarding-pediatric-studies-w-972627

    ACCESSWIRE
    23 Jan 2025
    Share Share
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program
    IRLAB Reports Progress Ahead of Mesdopetam Phase III Program

    29 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/936480/irlab-reports-continued-progress-ahead-of-the-mesdopetam-phase-iii-program

    ACCESSWIRE
    29 Oct 2024
    Share Share
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA
    IRLAB Receives End-of-Ph 2 Meeting Confirming Alignment with the FDA

    22 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/845836/irlab-receives-minutes-from-end-of-phase-2-meeting-confirming-alignment-with-the-fda-on-the-phase-iii-program-for-mesdopetam

    ACCESSWIRE
    22 Mar 2024
    Share Share
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data
    IRLAB Provides Update on Mesdopetam's Phase IIb Study Data

    21 Aug 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=775597&lang=en

    ACCESSWIRE
    21 Aug 2023
    Share Share
    IRLAB reports LPLV Achieved in Phase IIb Clinical Study of Mesdopetam
    IRLAB reports LPLV Achieved in Phase IIb Clinical Study of Mesdopetam

    14 Dec 2022

    // ACCESSWIRE

    https://www.accesswire.com/731758/IRLAB-reports-Last-Patient-Last-Visit-LPLV-Achieved-in-Phase-IIb-Clinical-Study-of-Mesdopetam-in-PD-LIDs-with-Top-Line-Results-Anticipated-Mid-January-2023

    ACCESSWIRE
    14 Dec 2022
    Share Share